<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27">
 <label>27</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Capdeville</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Buchdunger</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Zimmermann</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Matter</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug</article-title>
  <source>
   <italic toggle="yes">Nature Reviews Drug Discovery</italic>
  </source>
  <year>2002</year>
  <volume>1</volume>
  <issue>7</issue>
  <fpage>493</fpage>
  <lpage>502</lpage>
  <pub-id pub-id-type="doi">10.1038/nrd839</pub-id>
  <pub-id pub-id-type="other">2-s2.0-0036635291</pub-id>
  <pub-id pub-id-type="pmid">12120256</pub-id>
 </element-citation>
</ref>
